Why is DVT important for Insurance Companies?


DVT is an increasing condition that affects as many as 900,000 people (1 to 2 per 1,000) each year in the United States. Estimates suggest that 60,000-100,000 Americans die of DVT/PE each year.

10 to 30% of people will die within one month of diagnosis.

Sudden death is the first symptom in about 25% of people who have a PE. Among people who have had a DVT, one-half will have long-term complications(post-thrombotic syndrome) such as swelling, pain, discoloration, and scaling in the affected limb. One-third(about 33%) of people with DVT/PE will have a recurrence within 10 years. Approximately 5 to 8% of the U.S. population has one of several genetic risk factors, also known as inherited thrombophilias in which a genetic defect can be identified that increases the risk for thrombosis. (according to https://www.cdc.gov/ncbddd/dvt/data.html)

Hospital Re-admissions: When a patient must be readmitted to the hospital because of post-surgical DVT, the result can be devastating for everyone involved.

Fact is, nearly 50 percent of all DVT cases happen after a patient is discharged. Our product reduce this risk to patients- and their providers- by decreasing the likelihood of life-threatening, post-surgical DVT during the VULNERABLE first week after discharge. Designed to promote the continuum of care from the hospital to home after surgery, Circul8 is compact, portable and easy for patients to use. The result is greater compliance, positive patient experiences and better outcomes.

Never Events: Medical errors that should not happen are called "never events."

They not only harm patients, but hospitals as well, resulting in costly fines or loss of reimbursement. The Centers for Medicare & Medicaid Services have deemed DVT a never event. Still, DVT is the leading cause of preventable hospital deaths. Research shows one in 100 patients admitted to a hospital dies because of pulmonary embolism (PE), which is a result of DVT. Hospitals and surgical centers can affordably prevent life-threatening DVT never events with Circul8 take home DVT, using DVT prophylaxis will reduce the incidence of DVT never events during the post-operative period by two-thirds and will prevent death from PE in one patient out of every 200 major operations.

Cost to Prevent vs Treat: As with most other diseases, preventing DVT is substantially less expensive than treating its consequences.

The cost to diagnose and treat DVT and its effects in the Unites States is estimated to be as much as $23.8 billion per year. According to the Centers for Medicare & Medicaid Services (CMS), DVT treatment costs an average of $50,937 per patient.

We work with several Insurance companies that understand
the importance of DVT & DME.

Get to Know Who We Are

We welcome you to see who we are and what we represent. Watch our video below!

Watch Video

Want to learn more?

Fill out this form or call us directly at 800.993.8244